Mariëlle Ruijs

1.6k total citations
15 papers, 399 citations indexed

About

Mariëlle Ruijs is a scholar working on Oncology, Molecular Biology and Genetics. According to data from OpenAlex, Mariëlle Ruijs has authored 15 papers receiving a total of 399 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 8 papers in Molecular Biology and 7 papers in Genetics. Recurrent topics in Mariëlle Ruijs's work include Cancer-related Molecular Pathways (10 papers), Epigenetics and DNA Methylation (5 papers) and BRCA gene mutations in cancer (4 papers). Mariëlle Ruijs is often cited by papers focused on Cancer-related Molecular Pathways (10 papers), Epigenetics and DNA Methylation (5 papers) and BRCA gene mutations in cancer (4 papers). Mariëlle Ruijs collaborates with scholars based in Netherlands, United States and Finland. Mariëlle Ruijs's co-authors include Senno Verhoef, Margreet G.E.M. Ausems, Anja Wagner, Laura J. van’t Veer, Neil K. Aaronson, E. Gómez, Liesbeth Spruijt, Rolf H. Sijmons, Eveline M. A. Bleiker and A. H. J. T. Vriends and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Psycho-Oncology.

In The Last Decade

Mariëlle Ruijs

15 papers receiving 389 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mariëlle Ruijs Netherlands	10	209	207	135	108	62	15	399
Sonia Nanda Canada	7	190 0.9×	141 0.7×	234 1.7×	108 1.0×	34 0.5×	8	426
Jennifer L. Geurts United States	9	245 1.2×	136 0.7×	290 2.1×	102 0.9×	26 0.4×	27	505
Helen Byers United Kingdom	14	183 0.9×	217 1.0×	429 3.2×	144 1.3×	22 0.4×	30	651
Lise Sveen United States	9	389 1.9×	247 1.2×	450 3.3×	211 2.0×	43 0.7×	18	738
Alexandra Lebensohn United States	6	96 0.5×	111 0.5×	192 1.4×	115 1.1×	18 0.3×	10	323
Harris Australia	3	205 1.0×	252 1.2×	97 0.7×	101 0.9×	40 0.6×	5	392
Steven Keiles United States	8	101 0.5×	118 0.6×	281 2.1×	131 1.2×	42 0.7×	13	558
Jacqueline Mersch United States	3	185 0.9×	173 0.8×	333 2.5×	148 1.4×	17 0.3×	9	544
Josef Herzog United States	11	309 1.5×	147 0.7×	584 4.3×	183 1.7×	28 0.5×	33	724
Nicolette M. Chun United States	9	142 0.7×	58 0.3×	262 1.9×	119 1.1×	27 0.4×	24	382

Countries citing papers authored by Mariëlle Ruijs

Since Specialization

Citations

This map shows the geographic impact of Mariëlle Ruijs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mariëlle Ruijs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mariëlle Ruijs more than expected).

Fields of papers citing papers by Mariëlle Ruijs

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mariëlle Ruijs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mariëlle Ruijs. The network helps show where Mariëlle Ruijs may publish in the future.

Co-authorship network of co-authors of Mariëlle Ruijs

This figure shows the co-authorship network connecting the top 25 collaborators of Mariëlle Ruijs. A scholar is included among the top collaborators of Mariëlle Ruijs based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mariëlle Ruijs. Mariëlle Ruijs is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Koster, Roelof, Luuk J. Schipper, Daphne M. van Beek, et al.. (2023). Impact of genetic counseling strategy on diagnostic yield and workload for genome-sequencing-based tumor diagnostics. Genetics in Medicine. 26(2). 101032–101032. 2 indexed citations

Menko, Fred H., Kim Monkhorst, Frans B.L. Hogervorst, et al.. (2022). Challenges in breast cancer genetic testing. A call for novel forms of multidisciplinary care and long-term evaluation. Critical Reviews in Oncology/Hematology. 176. 103642–103642. 6 indexed citations

Ruijs, Mariëlle, et al.. (2020). Cumulative risk of skin cancer in patients with Li-Fraumeni syndrome. Familial Cancer. 19(4). 347–351. 5 indexed citations

Hogervorst, Frans B.L., Mary E. Velthuizen, Mariëlle Ruijs, et al.. (2019). TP53 germline mutation testing in early-onset breast cancer: findings from a nationwide cohort. Familial Cancer. 18(2). 273–280. 22 indexed citations

Moghadasi, Setareh, Luc Janssen, Mar Rodríguez‐Girondo, et al.. (2017). Performance of BRCA1/2 mutation prediction models in male breast cancer patients. Clinical Genetics. 93(1). 52–59. 3 indexed citations

Bleiker, Eveline M. A., Senno Verhoef, Margreet G.E.M. Ausems, et al.. (2011). Distress in partners of individuals diagnosed with or at high risk of developing tumors due to rare hereditary cancer syndromes. Psycho-Oncology. 20(6). 631–638. 24 indexed citations

Bleiker, Eveline M. A., Neil K. Aaronson, Anja Wagner, et al.. (2010). Regular surveillance for Li-fraumeni syndrome: advice, adherence and perceived benefits. Familial Cancer. 9(4). 647–654. 53 indexed citations

Aaronson, Neil K., Anja Wagner, Rolf H. Sijmons, et al.. (2010). Genetic Testing in Li-Fraumeni Syndrome: Uptake and Psychosocial Consequences. Journal of Clinical Oncology. 28(18). 3008–3014. 75 indexed citations

Ruijs, Mariëlle, Annegien Broeks, Fred H. Menko, et al.. (2009). The contribution of CHEK2 to the TP53-negative Li-Fraumeni phenotype. Hereditary Cancer in Clinical Practice. 7(1). 4–4. 29 indexed citations

10.

Bleiker, Eveline M. A., Neil K. Aaronson, A. H. J. T. Vriends, et al.. (2009). Attitude towards pre-implantation genetic diagnosis for hereditary cancer. Familial Cancer. 8(4). 457–464. 40 indexed citations

11.

Atwal, Gurinder S., Raúl Rabadán, Guillermina Lozano, et al.. (2008). An Information-Theoretic Analysis of Genetics, Gender and Age in Cancer Patients. PLoS ONE. 3(4). e1951–e1951. 18 indexed citations

12.

Hest, Liselotte P. van, Mariëlle Ruijs, Anja Wagner, et al.. (2007). Two TP53 germline mutations in a classical Li-Fraumeni syndrome family. Familial Cancer. 6(3). 311–316. 8 indexed citations

13.

Ruijs, Mariëlle, Marjanka K. Schmidt, Heli Nevanlinna, et al.. (2006). The single-nucleotide polymorphism 309 in the MDM2 gene contributes to the Li–Fraumeni syndrome and related phenotypes. European Journal of Human Genetics. 15(1). 110–114. 73 indexed citations

14.

Ruijs, Mariëlle, Senno Verhoef, Arno Floore, et al.. (2006). Late-Onset Common Cancers in a Kindred with an Arg213Gln TP53 Germline Mutation. Familial Cancer. 5(2). 169–174. 9 indexed citations

15.

Ruijs, Mariëlle, et al.. (2002). Atypical progeroid syndrome: An unknown helicase gene defect?. American Journal of Medical Genetics Part A. 116A(3). 295–299. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact